コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al of B lymphocytes in PBMC of patients with rotavirus infection.
2 r in intracellular calcium regulation during rotavirus infection.
3 ion of intestinal lymphoid hyperplasia after rotavirus infection.
4 the normal pathogenic sequence of homologous rotavirus infection.
5 ting non-human primates against experimental rotavirus infection.
6 ing intestinal epithelial gene expression in rotavirus infection.
7 L-12 in the induction of immune responses to rotavirus infection.
8 initiate intestinal B-cell activation during rotavirus infection.
9 significantly associated with G. lamblia and rotavirus infection.
10 ques (Macaca mulatta) was observed following rotavirus infection.
11 , immunology, and clinical manifestations of rotavirus infection.
12 rotavirus in vivo, we used a mouse model of rotavirus infection.
13 of the human intestinal cell line Caco-2 to rotavirus infection.
14 ldren were similar to those of children with rotavirus infection.
15 in intestinal epithelial cells and restricts rotavirus infection.
16 tralizing antibody responses upon subsequent rotavirus infection.
17 an active component of the host response to rotavirus infection.
18 rred only with cells that are permissive for rotavirus infection.
19 ells were completely unable to clear chronic rotavirus infection.
20 mples to determine the prevalence of group C rotavirus infection.
21 ion and modulation of the immune response to rotavirus infection.
22 hat lactadherin protects against symptoms of rotavirus infection.
23 ntranasal routes in the adult mouse model of rotavirus infection.
24 ve delayed but complete clearance of primary rotavirus infection.
25 induced following homologous or heterologous rotavirus infection.
26 a 1- to 4-day delay in clearance of primary rotavirus infection.
27 in western New York have experienced group C rotavirus infection.
28 T cells from perforin +/+ mice in clearing a rotavirus infection.
29 the mechanism used by CD8+ T cells to clear rotavirus infection.
30 ice participate in the resolution of primary rotavirus infection.
31 atment led to a dose-dependent resistance to rotavirus infection.
32 e associated with partial protection against rotavirus infection.
33 tosis is a mechanism of host defense against rotavirus infection.
34 for IgA ASC responses in the intestine after rotavirus infection.
35 er T1D risk exhibit reduced activity against rotavirus infection.
36 re hyper-susceptible to initiation of murine rotavirus infection.
37 wing the development of laboratory-confirmed rotavirus infection.
38 tively associated with a risk of symptomatic rotavirus infection.
39 laboratory testing, diagnostic imaging, and rotavirus infection.
40 nd duration of diarrhea in male infants with rotavirus infection.
41 d B cell activation after in vivo intestinal rotavirus infection.
42 re not absolutely required in the setting of rotavirus infection.
43 han 5 years due to diarrhoea attributable to rotavirus infection.
44 riglycerides were significantly increased by rotavirus infection.
45 downregulation of lipid synthesis induced by rotavirus infection.
46 ets for antiviral development is limited for rotavirus infection.
47 transcription and IFN-beta secretion during rotavirus infection.
48 ge, 75% of children experienced a documented rotavirus infection.
49 ea, 131 (34%) were estimated to be caused by rotavirus infection.
50 ency to protect against murine norovirus and rotavirus infections.
51 ith concomitant HIV infection resolved acute rotavirus infections.
52 ally milder (diarrhea, vomiting, fever) than rotavirus infections.
53 derstanding of the host range restriction of rotavirus infections.
54 s potential as a new approach for control of rotavirus infections.
55 venting primary and resolving chronic murine rotavirus infections.
56 heir winter peaks, which have been linked to rotavirus infections.
57 teritis symptoms compared to that of natural rotavirus infections.
58 otects breastfed infants against symptomatic rotavirus infections.
59 and vaccine-reassortant strains in pediatric rotavirus infections.
60 tors are responsible for recovery from acute rotavirus infection?
62 o observed more commonly among patients with rotavirus infection (54% vs. 9%; P = .033 for both).
63 s crucial for the immune response to enteric rotavirus infection, a proposed etiological agent for T1
64 variables were significantly associated with rotavirus infection after adjusting for seasonality and
65 CD8+ cells were highly efficient at clearing rotavirus infection, alpha4beta7- memory cells were inef
66 the early stages of autophagy are initiated, rotavirus infection also blocks autophagy maturation.
68 consistent with the conclusion that natural rotavirus infection, an enteric pathogen, results in a s
69 irst examination was 3.0 mm in patients with rotavirus infection and 2.0 mm in control subjects (P =
71 ses were found to correlate with the risk of rotavirus infection and all P[8]/P[4] rotavirus infected
73 s, have also been shown to protect mice from rotavirus infection and clear chronic infection in SCID
75 were evaluated in a gnotobiotic pig model of rotavirus infection and disease and were compared to pre
76 hese results suggest that protection against rotavirus infection and disease is primarily VP7/VP4 hom
78 months of age) without evidence of previous rotavirus infection and examined for rotavirus antigen.
81 ound measurements, in infants with confirmed rotavirus infection and in healthy control subjects, of
83 n is required for viroplasm formation during rotavirus infection and is hyperphosphorylated into 32-
85 s determined characteristics of asymptomatic rotavirus infection and potential risk factors for infec
90 a model that characterized susceptibility to rotavirus infection and RVGE among children, accounting
91 ified greater variation in susceptibility to rotavirus infection and RVGE in Vellore than in Mexico C
93 Mexico City belong to a high-risk group for rotavirus infection and RVGE, and demonstrate that unmea
94 timate naturally-acquired protection against rotavirus infection and RVGE, and to understand how diff
96 ich intestinal epithelial cells (IECs) sense rotavirus infection and signal IFN-beta production, and
97 mic IgA is not essential for protection from rotavirus infection and suggest that in the absence of I
98 Experience gained through studies of natural rotavirus infection and the clinical trials for the curr
99 to assess the disease burden associated with rotavirus infection and the distribution of rotavirus st
100 pathogens, we evaluated the OPN response to rotavirus infection and the extent of diarrhea manifeste
101 Our study supported the association between rotavirus infection and the host HBGA phenotypes, which
102 omposing the incidence rate into the rate of rotavirus infection and the risk of RVGE given infection
104 sized that the gut microbiota might modulate rotavirus infection and/or antibody response and thus po
106 virus-unvaccinated children experienced 1418 rotavirus infections and 371 episodes of RVGE over 17,63
108 erval [CI], .16-.32) in laboratory-confirmed rotavirus infections and a 26% decline (RR, 0.74; 95% CI
109 tained declines in both laboratory-confirmed rotavirus infections and AGE hospitalizations across all
110 ith large reductions in laboratory-confirmed rotavirus infections and hospitalizations due to acute g
111 estimated the impact on laboratory-confirmed rotavirus infections and hospitalizations for all-cause
113 that antigenemia/viremia occurs routinely in rotavirus infections and imply that infectious rotavirus
114 iggering relationship between some wild-type rotavirus infections and T1D, but the potential effect o
115 ay have bearing on our full understanding of rotavirus infections and the effects of vaccination in d
116 ome activation upon mouse hepatitis virus or rotavirus infection, and in steady state stimulated by i
117 fferentially regulated >2-fold at 16 h after rotavirus infection, and only one gene was similarly reg
118 tric-scale organization of VPs formed during rotavirus infection, and quantitatively describe the str
119 emonstrated that viremia and extraintestinal rotavirus infection are common in acutely infected human
124 ells were rarely detectable in children with rotavirus infection at both acute and convalescent stage
125 to limited diagnosis of acute human group C rotavirus infections because no routine test is availabl
126 3 serum samples from children with confirmed rotavirus infection but in none of 35 samples from contr
128 pithelial cells are the principal targets of rotavirus infection, but the response of enterocytes to
129 immune response induced in the intestine by rotavirus infection, but vaccination with virus-like par
130 -1991) due to diarrhea and weekly reports of rotavirus infection by 74 laboratories were reviewed to
131 od of a 12-month increment, and detection of rotavirus infection by enzyme immunoassay in at least 10
132 lls lining the gastrointestinal tract combat rotavirus infection by two key antiviral compounds known
134 d a delay of 1 to 2 days in the clearance of rotavirus infection compared to the clearance time for u
137 more than half of all deaths attributable to rotavirus infection: Democratic Republic of the Congo, E
138 Microbiota ablation resulted in reduced rotavirus infection/diarrhea and a more durable rotaviru
142 IFNs could efficiently protect cells against rotavirus infection, endogenous type III IFNs were found
143 pe for preventing the severe consequences of rotavirus infection, especially in resource-limited sett
144 pitalizations, and 20 to 40 deaths caused by rotavirus infections every year in the United States.
146 apable of unambiguously discriminating mixed rotavirus infections from nonspecific cross-reactivity;
147 hildren presenting with laboratory-confirmed rotavirus infection had higher proportions of effector a
148 result from altered intestinal motility, but rotavirus infection had no effect on gastrointestinal tr
149 T cell-mediated immune protection following rotavirus infection has been observed in animal models,
152 ics and patterns of cytokine responses after rotavirus infection has important implications for induc
153 ntroduced, the number of laboratory-detected rotavirus infections has been consistently lower than du
154 s vaccine would prevent 70% of deaths due to rotavirus infection if administered without age restrict
156 ly assess the role of IgA in protection from rotavirus infection, IgA knockout mice, which are devoid
157 man milk was associated with delayed time to rotavirus infection, implying protective properties of a
160 findings highlight the significant burden of rotavirus infection in Africa, and underscore the need f
162 day care was a risk factor for asymptomatic rotavirus infection in children under age 5 years; livin
164 han IgG were responsible for protection from rotavirus infection in IgA knockout mice, mice were depl
166 er's patch B cell activation associated with rotavirus infection in mice requires dendritic cells, we
169 ed CD8+ T cells mediate clearance of primary rotavirus infection in mice: JHD knockout (JHD -/-) (B-c
170 ole in mitigating clinical disease following rotavirus infection in neonatal swine and that the prote
171 ns identified during nosocomial outbreaks of rotavirus infection in New Delhi and Bangalore, India, m
173 multicountry birth cohort study, we describe rotavirus infection in the first 2 years of life in site
174 explained 5.9% to 6.2% of the variability in rotavirus infection in the pooled data and their predict
175 lobule membrane glycoprotein, inhibits human rotavirus infection in vitro, whereas bovine lactadherin
177 Reductions of 69-83% in laboratory-confirmed rotavirus infections in all age groups and 77-88% in inf
184 omach, bone, or lung were all susceptible to rotavirus infection, indicating a wider host tissue rang
185 t molecular basis for understanding neonatal rotavirus infections, indicating that glycan modificatio
187 levels in acute-phase PBMC, we conclude that rotavirus infection induces robust proinflammatory and a
189 pecific CD8 T cells in multiple organs after rotavirus infection initiated via the intranasal, oral,
191 /41, astrovirus, nonpolio enteroviruses, and rotavirus) infections, interference among Sabin vaccine
202 ation of both the rabbit and mouse models of rotavirus infection is that human rotavirus (HRV) strain
210 We extracted data on laboratory-confirmed rotavirus infections (July 2000 through June 2015) and a
212 inflammatory protein-1beta expression during rotavirus infection localized to the intestinal epitheli
213 revented injury of the duct epithelium after rotavirus infection, maintained continuity of duct lumen
215 As childhood nutrition improves worldwide, rotavirus infection may remain a public health challenge
216 ell culture), we hypothesized that such dual-rotavirus infections might play a role in the pathogenes
217 egression analysis showed that resistance to rotavirus infection most closely correlated with higher
218 s, G1P[8] strains constitute the majority of rotavirus infections most years, but occasionally other
228 In this study, we used an in vivo model of rotavirus infection of mouse gallbladder with UK x RRV r
230 o better understand mechanisms of persistent rotavirus infections of cultured cells, we established i
231 re selected during maintenance of persistent rotavirus infections of MA104 cells and suggest that mut
234 fected PKR(-/-) MEFs, indicating that during rotavirus infection, PKR functions at a stage between IF
236 rted by studies demonstrating that wild-type rotavirus infection protects against subsequent rotaviru
237 ses following either natural or experimental rotavirus infection provide protection against subsequen
239 Worldwide in 2008, diarrhoea attributable to rotavirus infection resulted in 453,000 deaths (95% CI 4
242 rstood, but in analogy to Gardia lamblia and rotavirus infections, secondary lactose maldigestion (LM
245 a suite of hydrometeorological variables and rotavirus infection status ascertained through community
246 For this analysis of multisite cohort data, rotavirus infection status was ascertained through commu
247 ession recapitulated this rare resistance to rotavirus infection, suggesting a previously unrecognize
248 ted 5-fold by VP8* and were not activated by rotavirus infection, suggesting the differential regulat
251 he clinical presentation and pathogenesis of rotavirus infection, the associated global disease burde
253 osal pDCs critically influence the course of rotavirus infection through rotavirus recognition and su
257 A was induced in balb/cAnNCrl mice by rhesus rotavirus infection; uninfected mice were used as contro
258 ccine with use of data on health outcomes of rotavirus infection, vaccine effectiveness, and immuniza
259 eptibility to SA-dependent or SA-independent rotavirus infection varied depending on the cell line te
260 une responses to homologous and heterologous rotavirus infection vary both quantitatively and qualita
261 The age-adjusted prevalence of asymptomatic rotavirus infection was 11%; prevalence was highest in c
262 The maximum lymph node size in patients with rotavirus infection was 11.6 mm at the first examination
263 s, the percentage reduction in deaths due to rotavirus infection was 53%, 66%, and 69%, respectively.
264 en immediately before an infant's episode of rotavirus infection was assayed for lactadherin, butyrop
269 he degree of protection conferred by natural rotavirus infection was estimated through analyses of da
273 To identify correlates of resistance to rotavirus infection, we analyzed levels of serum immunog
274 To understand the role of cytokines during rotavirus infection, we assessed the kinetics of tumor n
275 ular mechanisms involved in the events after rotavirus infection, we identified host cellular genes w
276 es of hospitalization specifically coded for rotavirus infection were 14, 4, and 6 cases per 10,000 p
277 Human in vitro and murine in vivo models of rotavirus infection were used to delineate the role of p
279 infection provided complete protection from rotavirus infection when rabbits were challenged orally
280 e syncytia with cells that are permissive to rotavirus infection whereas nonpermissive cells are refr
281 e importance of type III IFNs in controlling rotavirus infection, which could be exploited as antivir
282 ving childhood vaccines for pneumococcal and rotavirus infections while greatly expanding coverage of
283 s in our understanding of the mouse model of rotavirus infection will enhance the understanding of hu
284 the biology, immunology, and pathogenesis of rotavirus infection will help to explain the strengths a
286 -/-) mice and lpr (fas-deficient) mice clear rotavirus infection with the same kinetics as control mi
287 n anti-IFN-gamma monoclonal antibody cleared rotavirus infection with the same kinetics as those for
288 pare exposures reported by participants with rotavirus infection with those of participants who teste
291 indicate a balanced Th1/Th2 response during rotavirus infection, with higher cytokine levels early a